Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Short Interest Up 30.1% in February

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) was the recipient of a significant growth in short interest during the month of February. As of February 13th, there was short interest totaling 95 shares, a growth of 30.1% from the January 29th total of 73 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 7,082 shares, the days-to-cover ratio is presently 0.0 days. Based on an average daily trading volume, of 7,082 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the shares of the company are short sold.

Bitwise MARA Option Income Strategy ETF Stock Performance

Shares of NYSEARCA IMRA traded up $0.89 during mid-day trading on Wednesday, hitting $14.77. The stock had a trading volume of 2,339 shares, compared to its average volume of 6,284. The firm has a market cap of $3.54 million, a PE ratio of 295.40 and a beta of -6.67. The company has a 50 day moving average of $15.21 and a two-hundred day moving average of $25.24. Bitwise MARA Option Income Strategy ETF has a twelve month low of $11.99 and a twelve month high of $60.73.

Bitwise MARA Option Income Strategy ETF Company Profile

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.